Where does Hikma Pharmaceuticals USA Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hikma Pharmaceuticals USA Inc. ranks #11,669 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hikma Pharmaceuticals USA Inc. hold?

Hikma Pharmaceuticals USA Inc. holds 26 US utility patents granted between 2019 and 2025, spanning 8 technology areas.

What is Hikma Pharmaceuticals USA Inc.'s Innovation Score?

Hikma Pharmaceuticals USA Inc. has an Innovation Score of 38.2 out of 100 (top 41% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hikma Pharmaceuticals USA Inc. focus on?

Hikma Pharmaceuticals USA Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 25 patents, ranking #906 of 7,163 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Hikma Pharmaceuticals USA Inc.'s patent grant rate increasing or decreasing?

Hikma Pharmaceuticals USA Inc.'s recent grant velocity is +2100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Hikma Pharmaceuticals USA Inc.'s patents?

Hikma Pharmaceuticals USA Inc.'s patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hikma Pharmaceuticals USA Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Hikma Pharmaceuticals USA Inc.

USPTO PatentsView assignee record - 26 granted patents across 8 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hikma ranks #11,669 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 8 technology areas.

#11,669
of 49,997 US assignees by volume: Top 41%
by Innovation Score (38.2/100): 15.9
avg claims per patent: +2100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11669 · US Corporation #11,669 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,669/49,997
PHOTO-FINISH Hangzhou Glority…
CPC-NARROW A61K · 8 areas
INNOV-THIN 38.2/100
CLAIMS-RICH 15.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +2100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hangzhou Glority Software Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hikma’s 38.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (30%) Velocity 7.3 pts (19%) Breadth 10.0 pts (26%) Claim depth 9.5 pts (25%)

Qualcomm Incorporated · highest

85
Byton · near

38
Centre Firearms · near

38
Hikma Pharmaceutical… · this assignee

38
Signal Pharmaceuticals · near

38
Institut DE… · near

38
3D Lighting… · lowest

7

What this shows Hikma's Innovation Score is 38.2/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hikma?

Each dot is one of Hikma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hikma’s own 15.9 claims/patent is ABOVE the 6.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hikma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hikma's grants concentrate

Hikma Pharmaceuticals USA Inc. is a focused PatentsView assignee: 8 CPC subclasses with 96.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2019. By volume, Hikma sits between Husky Corporation and Ikeda Food Research Co., Ltd..

Hikma's three-year grant acceleration

Hikma Pharmaceuticals USA Inc. shows 12 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Husky

26
Hangzhou Glority…

26
Healgen Scientific

26
Helmholtz-zentrum…

26
Hubei University

26
Humancentric Vent…

26
Idtp Holdings

26
Ikeda Food Resear…

26
Hikma Pharmaceuti… ◀

26

What this shows Hikma holds 26 patents at rank #11,671, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hikma

By rank, the assignees closest to #11,671 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Hikma's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Hikma, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Hikma ranks #906 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Centre Firearms Co., Inc. 38 Byton Limited 38 Signal Pharmaceuticals, LLC 38 Institut DE Recherche Pour LE Developpement 38

Hikma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 41% higher than 59% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Hikma Pharmaceuticals USA Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	3.8%
2020	4	15.4%
2021	6	23.1%
2022	2	7.7%
2023	6	23.1%
2024	4	15.4%
2025partial year	3	11.5%

Which technologies does Hikma Pharmaceuticals USA Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 25

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 4

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

B67C - Cleaning, Filling With Liquids OR Semiliquids, OR Emptying, OF Bottles, Jars, Cans, Casks, Barrels, OR Similar Containers, NOT Otherwise Provided FOR; Funnels 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hikma Pharmaceuticals USA Inc.'s patent record in context - here's where to go next.

Hikma Pharmaceuticals USA Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 96.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #11,669 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hikma Pharmaceuticals USA Inc. against Husky Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.